Meet us at BIO-EUROPE 2025 in Vienna (AT)

Posted on : |

We are pleased to announce that Dendrogenix will be attending BIO-Europe 2025 in Vienna, November 3–5. As one of Europe’s leading partnering events for the biopharma industry, BIO-Europe brings together biotech innovators, pharmaceutical companies, and investors to foster new collaborations and accelerate life science innovation. Our team will be presenting our ongoing clinical development programs and exploring strategic partnerships and private funding opportunities to advance our pipeline.

DENDROGENIX S.A.

Founded in 2018, Dendrogenix develop first-in-class molecules, Dendrogenins, to address high unmet medical needs in hearing loss and neurology.

© 2024 Dendrogenix